Buscar

Mostrando ítems 1-10 de 38

Recombinant Activated Factor Vii In The Treatment Of Bleeds And For The Prevention Of Surgery-related Bleeding In Congenital Haemophilia With Inhibitors.

Santagostino, Elena; Escobar, Miguel; Ozelo, Margareth; Solimeno, Luigi; Arkhammar, Per; Lee, Hye Youn; Rosu, Gabriela; Giangrande, Paul (2015)

Prevention of bleeding in hemophilia patients with high-titer inhibitors

Leissinger, Cindy A.; Konkle, Barbara A.; Antunes, Sandra V. [UNIFESP] (Expert Reviews, 2015-06-01)

Inhibitor development is the most serious adverse event linked to the treatment of hemophilia, as it renders standard hemostatic therapy ineffective. Consequently, inhibitor patients are at increased risk for difficult-to-control ...

Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome

Ozelo, MC; Svirin, P; Larina, L (SpringerNew YorkEUA, 2005)

Uso de factor VII en el control de sangrados perioperatorios: Evidencias actuales

López B,Rodrigo; Aeschlimann D,Nicolás; Carvajal F,Claudia; Lema F,Guillermo (Sociedad Médica de Santiago, 2009)

Recombinant Activated Factor Vii In The Treatment Of Bleeds And For The Prevention Of Surgery-related Bleeding In Congenital Haemophilia With Inhibitors

Santagostino; Elena; Escobar; Miguel; Ozelo; Margareth; Solimeno; Luigi; Arkhammar; Per; Lee; Hye Youn; Rosu; Gabriela; Giangrande; Paul (CHURCHILL LIVINGSTONEEDINBURGH, 2015)

A Cost Evaluation Of Treatment Alternatives For Mild-to-moderate Bleeding Episodes In Patients With Haemophilia And Inhibitors In Brazil.

Ozelo, M C; Villaça, P R; De Almeida, J O S C; Bueno, T M F; De Miranda, P A P; Hart, W M; Karamalis, M (2007)

Diagnosis And Treatment Of Congenital Hemophilia With Inhibitors. A Latin American Perspective

Bianco R.P.; Ozelo M.C.; Villaca P.R.; Solano M.H.; Cruz G.J.; Murillo C.M.; Chavez J.G.; Mendoza S.; Grecco I.R.; Ruiz-Saez A. (, 2008)

Key Issues In Inhibitor Management In Patients With Haemophilia

Gomez K.; Klamroth R.; Mahlangu J.; Mancuso M.E.; Mingot M.E.; Ozelo M.C. (, 2014)

Long-acting Recombinant Factor Ix Fc Fusion Protein (rfixfc) For Perioperative Management Of Subjects With Haemophilia B In The Phase 3 B-long Study

Powell J.S.; Apte S.; Chambost H.; Hermans C.; Jackson S.; Josephson N.C.; Mahlangu J.N.; Ozelo M.C.; Peerlinck K.; Pasi J.; Perry D.; Ragni M.V.; Wang X.; Jiang H.; Li S.; Cristiano L.M.; Innes A.; Nugent K.; Brennan A.; Luk A.; Allen G.; Pierce G.F.; Robinson B. (Blackwell Publishing Ltd, 2015)

A Cost Evaluation Of Treatment Alternatives For Mild-to-moderate Bleeding Episodes In Patients With Haemophilia And Inhibitors In Brazil

Ozelo M.C.; Villaca P.R.; De Almeida J.O.S.C.; Bueno T.M.F.; De Miranda P.A.P.; Hart W.M.; Karamalis M. (, 2007)